Skip to main content
. 2023 Mar 20;29(3):670–689. doi: 10.3350/cmh.2022.0103

Table 1.

Definitions by various societies and its differences

Variables APASL [1] NASCELD [6] EASL [4]
Defined patient group First episode in compensated cirrhosis or non-cirrhotic CLD Patients with acutely decompensated cirrhosis, with or without prior episode(s) of decompensation Acute decompensation in cirrhosis patient with or without prior decompensation
Acute insult Hepatic only Variceal bleed is considered as insult if it results in liver failure Extra-hepatic Hepatic or extra-hepatic
Variceal bleed is considered as precipitant
Organ failure Liver-central to pathogenesis Any of the 4 Any of 6
Cardiac (shock), hepatic encephalopathy, renal (need for dialysis), respiratory (need for mechanical ventilation) Liver/cardiac/renal/circulatory/coagulant/respiratory
Duration Acute insult leading to development of ACLF with in 4 weeks No specific duration specified No specific duration specified
Definition basis Liver involvement is the central cause and subsequently other extrahepatic organ failures follow Existence of 2 or more organ system failures Based on existence of 1 of the six organ failures and CLIF-C score is used to categorize
AARC score is used to stratify
Mortality Grade 1-13% 2 OF-49% Grade 1-20%
Grade 2-45% 3 OF-64% Grade 2-30%
Grade 3-86% 4 OF-77% Grade 3-80%

ACLF, acute on chronic liver failure; APASL, Asian pacific Association for study of liver; NASCELD, North American Consortium for the Study of End-Stage Liver Disease; EASL, European association of study of liver; AARC, APASL ACLF research consortium score; MELD, Model for end stage liver disease; CLIF C-ACLF, chronic liver failure consortium acute-on-chronic liver failure; CLD, chronic liver disease; OF, organ failure.